Guide for patients & caregivers
What Does Immunohistochemistry (IHC) Mean on a Pathology Report?
Immunohistochemistry on a pathology report explained: what IHC stains are, what positive or negative markers mean, why results take longer, and what to ask.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What is immunohistochemistry on a pathology report?
Immunohistochemistry (IHC) is a test done on a tissue sample in the laboratory. Antibodies that recognise a specific protein are added to a thin slice of the sample, and a linked chemical turns cells a certain colour if that protein is present. The pathologist then looks under the microscope to see which cells stain.
On a report, IHC may appear as 'immunohistochemistry', 'immunostains', 'IHC panel' or simply 'stains', often followed by a list of marker names marked positive or negative. This guide explains the general idea. It cannot interpret a particular marker or report.
When should you seek help sooner while waiting?
Waiting for extra tests is about the laboratory, not about your symptoms, and new symptoms should not wait for a report. If something new or worrying develops, contact the team looking after you, a GP or a local urgent advice line.
After the biopsy itself, NHS advice is to seek help if pain is getting worse despite painkillers, you have a high temperature, blood or fluid is oozing from the site, or the area becomes swollen or red. For severe symptoms such as difficulty breathing or heavy bleeding, call local emergency services.
How is IHC different from the routine H&E stain?
Almost every tissue sample is first stained with haematoxylin and eosin, usually shortened to H&E. According to the US National Cancer Institute, this routine stain colours cell nuclei blue-purple and the surrounding parts pink-red, showing the shape and arrangement of cells.
H&E shows what cells look like. IHC adds information about what proteins they carry. Some cells look alike under H&E but carry different markers, so pathologists use IHC to tell them apart. Other 'special stains' that are not antibody-based may also be listed.
Why would a pathologist order IHC stains?
Pathologists choose IHC when the routine slides leave a question that a marker can help answer. Common reasons include:
- Working out what type of cell is present, for example whether cells come from the lining of an organ, from the immune system or from another tissue.
- Confirming or ruling out a possible diagnosis when the appearance under H&E is not conclusive.
- Helping identify which type of cell a cancer started in. Cancer Research UK explains that IHC tests can sometimes do this when the original site is unclear.
- Measuring markers that guide treatment choices. In breast cancer, for example, the National Cancer Institute notes that reports include testing for oestrogen and progesterone receptors and the HER2 protein.
- Helping with harder cases in general: one NHS histopathology department describes using stains in the diagnosis of various diseases and conditions, not only cancer.
What do 'positive' and 'negative' stains mean?
A positive marker means the protein was seen in the cells being studied. A negative marker means it was not seen. Neither word means good or bad by itself. Reports often list several markers, and the pathologist reads them together with how the cells look.
Some reports give a percentage of cells staining, an intensity, or a score. How these are reported and which thresholds matter depend on the marker, the tissue and the laboratory's methods. Cleveland Clinic notes that not all laboratories follow identical procedures, so results can vary a little between labs.
Cleveland Clinic also stresses that clinicians consider these results alongside symptoms and other tests, and that a cancer diagnosis is unlikely to rest on this type of test alone.
Why do IHC results take longer?
Tissue is first fixed, embedded in wax, cut into very thin slices and stained, which the National Cancer Institute says normally takes several days. IHC is done on extra slices after the pathologist has looked at the first slides, so it adds another step.
One NHS hospital histopathology department says special stains and immunohistochemistry can take a further one to two working days. Some less common stains are sent to another laboratory and normally take an additional week. In those cases a report may be issued first, with the stain results added later as a supplementary report.
The NHS says biopsy results can take a few weeks or more, and that you should contact your healthcare team or GP surgery if you hear nothing after a few weeks. A delay for stains is common and does not by itself suggest anything about the result.
Where do stain results appear on the report?
The National Cancer Institute describes a pathology report as having a description of the sample, a microscopic description and a final diagnosis, sometimes with a comments section. Stain results may sit in the microscopic description, in a separate list of markers, or in the comments.
Results of additional tests may also come as separate reports linked to the main one, and the comments section can mention tests that are still pending. If a report says 'see addendum' or 'supplementary report to follow', it is not yet the full picture.
The doctor in charge of care usually explains the findings. The National Cancer Institute notes that patients can also ask to discuss the report with the pathologist, and that a second pathology opinion is possible by sending the slides or tissue block.
Questions to ask about stains on your report
Bring the written report, including any supplementary or addendum reports, to your appointment.
- What question were the stains ordered to answer?
- Is this the final report, or are any stains or other tests still pending?
- Which markers matter most for my diagnosis or treatment, and why?
- Do the IHC results fit with the scans and how the sample looked on routine slides?
- Would a second pathology opinion on the slides be useful in my situation?
- Who will tell me when the remaining results are back, and how?
How comparing similar cases on SameCase can help
On SameCase, patients and verified doctors share de-identified cases. Seeing how other people's reports listed stains, and what they asked their care team, can help you prepare clear questions about your own report.
Marker names on someone else's report do not tell you what yours mean, and no case can predict an outcome. Use similar cases to organise questions, and rely on your pathologist and treating clinician for interpretation.
Sources and further reading
- National Cancer Institute: Pathology reports fact sheet (H&E, processing time, additional tests, pending results)
- Cleveland Clinic: Immunophenotyping, including the immunohistochemistry technique and its limits
- Dorset County Hospital NHS Foundation Trust: Histopathology, special stains, immunohistochemistry and turnaround times
- NHS: Biopsy, complications and getting results (reviewed June 2025)
- Breast Cancer Now: Hormone receptors and breast cancer
- Cancer Research UK: Biopsy and what a pathologist checks (reviewed April 2025)
- Cancer Research UK: Tests on cancer cells, including immunohistochemistry (reviewed May 2024)
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.